跳至主要内容
临床试验/NL-OMON51568
NL-OMON51568招募中不适用

Changes in gut- and vaginal microbiome composition in association with PCOS clinical phenotypes - GuVa PCOS study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age 18-45years (premenopausal)
  • - Caucasian
  • - Willing to provide vaginal swab and stool sample
  • - Willing to provide informed consent
  • - Sufficient command of the Dutch language
  • - Diagnosed with PCOS at Erasmus MC using the Rotterdam criteria by a presence
  • of at least two of the following criteria
  • o Clinical or biochemical hyperandrogenism (modified Ferriman-Gallway score >5;
  • testosterone level >2nmol/L, Free Androgen Index > 2.9)
  • o Oligomenorrorrhea or amenorrhea
  • o Polycystic ovaries.
  • Control group:
  • o Age 18-45years
  • o Caucasian
  • o Willing to provide vaginal and stool sample
  • o Willing to provide informed consent
  • o Regular menstrual cycle (25-35days)
  • o Sufficient command of the Dutch language
  • o No history of diagnosed PCOS and do not meet any of the Rotterdam criteria.

排除标准

  • - BMI <18
  • - Diabetes Mellitus or use of insulin sensitizer
  • - Chronic and acute infection diseases
  • - Endometriosis (American Fertility Score (AFS) III/IV)
  • - Elevated prolactin levels, thyroid disease, Cushing disease or
  • gastro-intestinal disease
  • - The use of hormonal contraceptives, other steroid hormones in last 3 months
  • - Use of antibiotics, probiotics or laxatives in the last 3 months
  • The exclusion criteria also applies to the control group

研究者

相似试验